[144] KEWAUNEE SCIENTIFIC CORP /DE/ SEC Filing

Rhea-AI Filing Summary

Kewaunee Scientific Corp (KEQU) filed a Form 144 reporting a proposed sale of 6,880 shares of common stock to be sold through Ameriprise Financial Services, LLC on 10/01/2025. The filing states an aggregate market value of $293,432.00 and lists 2,865,694 shares outstanding. The securities were acquired on 10/01/2025 as equity compensation from Kewaunee Scientific Corporation, with payment recorded as equity compensation on the same date. The filer reports no securities sold in the past three months and includes the standard signature representation that no undisclosed material adverse information is known.

Positive

• Required disclosure completed: Form 144 filed with broker, shares, value, acquisition details, and proposed sale date disclosed
• Broker identified: Ameriprise Financial Services, LLC is listed as the executing broker
• Acquisition method specified: Securities were acquired as equity compensation

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider notice of planned sale; disclosed quantity, value, acquisition method, broker, and timing.

The Form 144 provides the required disclosure for a proposed sale under Rule 144: the class (common stock), the broker (Ameriprise Financial Services, LLC), the quantity (6,880 shares), the aggregate market value ($293,432.00), the date of proposed sale (10/01/2025) and the date and nature of acquisition (10/01/2025, equity compensation). The filing also states the number of shares outstanding (2,865,694) and reports no sales in the prior three months. From a market-impact perspective, the document supplies standard transparency for an intended sale; it does not include additional context about the seller's identity beyond the required representations.

Compliance/Risk Analyst

TL;DR: Filing appears procedurally complete for Rule 144 requirements but contains limited substantive context.

The submission lists broker details and the statutory representation regarding material information and trading plans. It confirms acquisition and payment were via equity compensation on the acquisition date. The filing does not report any prior three-month sales and includes the standard criminal-statements reminder. For compliance review, the document includes the core fields expected on Form 144 but omits any explanatory remarks beyond the statutory representation.

10/01/2025 - 02:32 PM

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Ameriprise Financial Services, LLC 70100 Ameriprise Financial Center Minneapolis MN 55474	6880	293432.00	2865694	10/01/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/01/2025	Equity Compensation	Kewaunee Scientific Corporation			6880	10/01/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does KEQU's Form 144 report about the proposed sale?

The Form 144 reports a proposed sale of 6,880 common shares through Ameriprise Financial Services on 10/01/2025 with an aggregate market value of $293,432.00.

How many Kewaunee Scientific shares are outstanding according to the filing?

The filing lists 2,865,694 shares outstanding.

How were the securities being sold acquired?

The securities were acquired on 10/01/2025 as equity compensation from Kewaunee Scientific Corporation.

Did the filer report any securities sold in the past three months?

No. The Form 144 indicates Nothing to Report for securities sold during the past three months.

Which broker is named to execute the sale in the Form 144?

The named broker is Ameriprise Financial Services, LLC, located at Ameriprise Financial Center, Minneapolis, MN 55474.